Background and Aims: Various aspects of retracted articles authored by Yoshitaka Fujii and their retraction notices have been examined. Yuhji Saitoh has coauthored many articles with Yoshitaka Fujii which were subsequently retracted. Japanese Society of Anesthesiology (JSA) recommends retraction of various articles by Yuhji Saitoh, but various attributes of those and their retraction notices have not been examined. Methods: A list of retracted articles was retrieved from PubMed, Retraction Watch Database and relevant journals. Their retraction notices were obtained from the journal's webpage. Predefined characteristics of the retracted articles and their retraction notices were evaluated against those proposed by Committee on Publication Ethics (COPE).
INTRODUCTION
Speedy retraction of fraudulent research and transparency of the whole process cannot be overemphasised. The Committee on Publication Ethics (COPE) has taken major initiatives to systematically approach this issue. But the credibility of the scientific community is under the shadow of the ever-growing phenomenon of research misconduct. Thus, there is an urgent need to understand different aspects of this phenomenon. Researchers have started to look into various characteristics of retracted articles and their retraction notices in the context of guidelines proposed by COPE. [1] Four anaesthesiologists, namely, Yoshitaka Fujii, Yuhji Saitoh, Joachim Boldt and Scott Reuben, are well-known researchers with highest numbers of articles retracted for research misconduct. [2] In fact, Yoshitaka Fujii leads the board. Yuhji Saitoh has coauthored frequently with him in many of those retracted articles. Except Yuhji Saitoh, the misdemeanour of the other three researchers has been discussed at length in peer-reviewed literature and received widespread media coverage. [3] [4] [5] Although Yuhji Saitoh was a frequent coauthor with Yoshitaka Fujii, statistical analysis by Carlisle and Loadsman cast doubt about data integrity in many Indian Journal of Anaesthesia | Volume 63 | Issue 7 | July 2019
articles by Yuhji Saitoh in which Yoshitaka Fujii was not a coauthor. [6] An investigation by Japanese Society of Anesthesiology (JSA) in to the accusation of fraud in articles by Yuhji Saitoh has recommended retraction of 10 papers and Yushitaka Fujii was not a coauthor in any of them. [7] Therefore, there is a need for close scrutiny of retraction of research by Yuhji Saitoh in which Yoshitaka Fujii was not a coauthor.
Thus, we aimed to analyse various characteristics of such retracted articles and their retraction notices in the context of guidelines proposed by COPE. We also aimed to examine the status of the articles mentioned in the report of JSA and Carlisle and Loadsman [Online Appendix S2: references, part 1]. [6, 7] 
METHODS
We searched PubMed to retrieve 'Retracted Publications' authored by Saitoh We visited the webpages of the journals which published the articles retrieved from the previous two searches. The retraction notices and the retracted articles were subsequently downloaded. The webpage of COPE was searched to find out whether the journals containing retracted articles or articles eligible for retraction were members of COPE. [8] An article was regarded as eligible for retraction if it was mentioned in the appendix of the investigation report of the JSA. [7] If they were not members of COPE, we planned to search the webpage of the relevant journal to find out whether COPE is referred to in their journal-related information sheet. Retraction notices were evaluated against the criteria for retraction notices endorsed by COPE [ Table 1 ].We also evaluated whether the PDF versions of the retracted papers are watermarked. [1] We also observed whether the articles that were found to have violated ethics by investigation by JSA are retracted. [7] The list of articles examined by Carlisle and Loadsman was retrieved and we investigated whether any of those were retracted. [6] We emailed the Editor of the journals that were yet to retract articles mentioned in the report by JSA.
Although the report about possible research misconduct in certain papers authored by Yuhji Saitoh was published in 18 th December 2016, we defined the date of eligibility for retraction as 25 th September 2017 (date on which the investigation report by JSA was published). [6, 10] Time duration taken for retraction was defined as the duration between date of eligibility for retraction and date of electronic publication (ahead of print) of its retraction notice. If it was not available, the first day of the month of its print publication was considered. We defined 'life time of the retracted articles' as the time duration between the date of publication and retraction. For calculation of the time durations, only the number of months was considered (e.g., if the duration was 162 months and 26 days, it was considered as 162 months).
All the electronic searches and email contacts were carried out on 5/1/2019 and relevant documents downloaded by the first author. Again on 6/1/2019, the search was repeated by the first author. The second author carried out the search on 7/1/2019 independently. Data were analysed with Microsoft Excel™ (2007), USA. Kaplan-Meier survival curve was generated with a freely available online software (http://eurekastatistics. com/kaplan-meier-survival-curve-grapher/). 
RESULTS
The search strategy used with results is mentioned in Figure 1 . Among the citations retrieved from Retraction Watch Database, 15 papers met inclusion criteria. All the citations retrieved from PubMed (13 numbers) were included in Retraction Watch Database. We gathered another retracted article from individual journal webpage search. Both these additional papers are available in PubMed, but none was flagged as retracted.
Eight journals published all the retracted or articles eligible for retraction. Seven were members of COPE. No reference to COPE could be found in the webpage of the remaining journal. Only 2 (13%) retraction notices complied with all the parameters mentioned in Table 1 All the retracted articles were available in the journal webpage, but 2 (13.3%) of them were not identified as retracted [Appendix 2]. The PDF version of these two articles was also not watermarked, and both were published by one journal. Among the 13 articles identified as retracted, the PDF of version of 2 (15.3%) articles was not watermarked. Although not watermarked, the retraction notice was made available along with the article in the PDF version of another article. Two retracted articles were not flagged as retracted in PubMed [Appendix 2]. Although JSA recommended for retraction, 5 (50%) articles were not retracted till the day of our search. [7] Among the 32 papers analyzed by Carlisle and Loadsman, one was not published. [6] Among those 31 published papers, 22 met our inclusion criteria and 10 among those have been retracted [Appendix 2]. Two journals contained articles deemed eligible for retraction by JSA but not retracted till 07/1/2019. [7] One journal is yet to respond to our email. The Editor-in-Chief of the other journal informed that 'the mail from JSA recommending the retraction of the article had not been forwarded to the editor-in-chief until the end of the last year due to administrative error' and they have 'just started appropriate procedures'. This article was subsequently retracted 3 months after our email to the journal editor. This retraction notice was not included in the results mentioned above.
DISCUSSION
We observed that although eligible for retraction, half of the papers are yet to be retracted and only 13.3% It is the responsibility of the scientific community to uphold the benchmark of ethics in science. Retraction is the only way to purge fraudulent researches, and a uniform retraction policy ensures its accuracy and relevance. But retraction policies of journal are not uniform. [11, 12] Absence of external or internal guidance may be some of the reasons for disparities in retraction policies. [11] The first guideline by COPE for retraction was published in 2009. [11] Although many journals lack a defined retraction policy, it is heartening to find that the number of journals with defined retraction policies is on the rise. [12] COPE, describing the code of conduct for journal editor, mentions that they should 'always be willing to publish corrections, clarifications, retractions and apologies when needed'.
[13] The COPE expects its members to follow it. But there may be many reasons why an editor may be reluctant to retract. [14] There are many intricacies and obstructions to initiate investigations of suspected research misconduct and its subsequent retraction. [15, 16] In our study, the prompt response by one journal is assuring, and it revealed that possible administrative issues in the editorial office may also hinder retraction. The keenness of a substantial number of journal editors and publishers to respond and act accordingly to queries about non-retraction of fraudulent research is encouraging. [1] We sincerely wished to receive some feedback from the journal editor of the other journal so as to have some more insight into the reason(s) for non-retraction of fraudulent research. JSA has urged 'respective journals to make retractions or take any other actions they deem necessary'. [7] These non-retractions reinforce the fact that that there is yet no mechanism Identified as retracted on bibliographic databases 13 (86.6%) PDF version is watermarked 11 (73.3%) The PDF version of these two articles was also not water marked, and they were published by one journal. Among the 13 articles identified as retracted, the PDF of version of 2 (15.3%) articles were not watermarked. Though not watermarked, the retraction notice was made available along with the article in the PDF version of another article that ensures retraction of article that warrants it. [17] In fact, many journal editors may be 'unaware of the need for retraction' of research deemed eligible for retraction. [1] The retraction of hundreds of papers tainted with scientific misconduct is welcome, but relevant organisations should construct mechanisms that mend the gap between report of investigative agency, the concerned journals and other stakeholders. We suggest that all the stakeholders must develop a common protocol to follow if any authoritative agency finds evidence of research misconduct. There must be mechanism to evaluate if that protocol is being followed. We expect COPE to take the lead.
Standardised retraction notices ensure complete and transparent information about retracted article. Across different specialties, sizeable numbers of retraction notices do not comply with the guidelines of COPE. [1, 18, 19] Except one, all the journals evaluated in our study are members of COPE. It is disconcerting that even being a member, a majority of retraction notices failed to comply the guidelines of COPE.
The better a database is in tracking retraction notices, the more easily retracted article can be identified. [19] We observed that search strategy using the name of author and the Publication Type Retraction of Publication failed to retrieve many relevant data. COPE suggests the use of name of author and title of the article in the heading of the retraction notice. [9] We believe that an unambiguous recommendation by COPE to use both will make retraction notices more visible in PubMed. Two of the retracted papers were not flagged by PubMed. Late indexation of retraction notices is known and it should be kept in mind while using PubMed. [20] A retracted paper is no longer a part of human knowledge. But in many instances, such articles get citations, many being positive citations. [19, 21] Such instances have tremendous ramifications. [22] Identification of retracted material is of unconditional importance. It is alarming that 20% articles were not identified as retracted in journal webpage or in PubMed. The widespread use of electronic devices increases the chance of unsuspecting authors to cite retracted article if it is not flagged in the journal webpage, electronic databases or lack of watermark in the PDF version. [1] We observed that the time from eligibility to actual retraction is lower than those for Fujii, Boldt and Reuben. [1] But it must be noted that many articles are still not retracted. The long duration taken for retraction from publication is notable. Science purges the fraudulent papers, but takes time. This time lag pollutes the literature and negates the very essence of science. This needs to be changed. Although the method proposed by Carlisle has generated debate, its application during review process is one courageous step. [23, 24] We would like to mention a few limitations of our study. The methodology used by Retraction Watch Database to collect information on retracted publication is not in public domain. Moreover, only a subset of journals is abstracted in PubMed and we searched the webpages of only those journals that have published either retracted publications or randomised trials with probable ethics violation. There must have been journals that published other types of paper by Yuhji Saitoh. Editor-in-Chief
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